Melatonin and Central nervous system lesion - a phase IV clinical study of FDA data

Summary:

Central nervous system lesion is reported as a side effect among people who take Melatonin (melatonin), especially for people who are female, 40-49 old, also take Vitamin D3, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Central nervous system lesion when taking Melatonin. It is created by eHealthMe based on reports of 53,570 people who have side effects when taking Melatonin from the FDA, and is updated regularly.

What is Melatonin?

Melatonin has active ingredients of melatonin. It is often used in insomnia. eHealthMe is studying from 56,212 Melatonin users. Check the latest studies of Melatonin.

What is Central nervous system lesion?

Central nervous system lesion (an abnormality in tissue of brain or spinal cord) is found to be associated with 780 drugs and 823 conditions by eHealthMe. Check the latest studies of Central nervous system lesion.

On Jul, 13, 2026

53,570 people reported to have side effects when taking Melatonin.
Among them, 74 people (0.14%) have Central nervous system lesion.

Could Melatonin cause Central nervous system lesion?

Among these 74 people:

What is the gender of people who have Central nervous system lesion when taking Melatonin? *

female: 61.97 %
male: 38.03 %

What is the age of people who have Central nervous system lesion when taking Melatonin? *

What are other drugs people take besides Melatonin? *

What are other side effects people have besides Central nervous system lesion? *

Headache (pain in head): 19 people, 25.68%
Fatigue (feeling of tiredness): 19 people, 25.68%
Pain: 19 people, 25.68%
Fever: 14 people, 18.92%
Weakness: 13 people, 17.57%
Diplopia (double vision): 12 people, 16.22%
Malaise (a feeling of general discomfort or uneasiness): 11 people, 14.86%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 14.86%
Muscle Spasms (muscle contraction): 10 people, 13.51%
Dizziness: 10 people, 13.51%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 29 people, 39.19%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 15 people, 20.27%
Gait Disturbance: 9 people, 12.16%
Pain: 9 people, 12.16%
Muscle Spasms (muscle contraction): 7 people, 9.46%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 8.11%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 6.76%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 4 people, 5.41%
Bone Density Decreased: 4 people, 5.41%
Constipation: 4 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Melatonin and have Central nervous system lesion?

- Check whether Central nervous system lesion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Melatonin:

Melatonin (56,212 reports)

Browse all side effects of Melatonin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Central nervous system lesion:

Central nervous system lesion (780 drugs)

Browse all the conditions that are associated with Central nervous system lesion:

Central nervous system lesion (823 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on melatonin (the active ingredients of Melatonin) and Melatonin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.